DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,721 | -8.4% | 185,170 | 0.0% | 3.98% | -6.8% |
| Q2 2023 | $44,441 | -4.8% | 185,170 | 0.0% | 4.27% | -8.9% |
| Q1 2023 | $46,670 | -5.0% | 185,170 | 0.0% | 4.69% | -2.8% |
| Q4 2022 | $49,148 | -99.9% | 185,170 | 0.0% | 4.82% | -9.9% |
| Q3 2022 | $47,828,000 | +1.9% | 185,170 | 0.0% | 5.35% | +6.4% |
| Q2 2022 | $46,944,000 | -13.6% | 185,170 | 0.0% | 5.03% | +3.1% |
| Q1 2022 | $54,316,000 | -13.5% | 185,170 | -3.0% | 4.88% | -16.9% |
| Q4 2021 | $62,798,000 | +8.4% | 190,870 | +0.3% | 5.87% | +1.0% |
| Q3 2021 | $57,932,000 | +14.0% | 190,290 | +0.5% | 5.81% | +15.9% |
| Q2 2021 | $50,814,000 | +19.7% | 189,350 | +0.4% | 5.02% | +12.2% |
| Q1 2021 | $42,459,000 | +1.3% | 188,640 | 0.0% | 4.47% | -4.5% |
| Q4 2020 | $41,904,000 | +3.2% | 188,640 | 0.0% | 4.68% | -9.3% |
| Q3 2020 | $40,620,000 | +21.8% | 188,640 | 0.0% | 5.16% | +12.8% |
| Q2 2020 | $33,357,000 | +11.7% | 188,640 | -12.6% | 4.57% | +8.3% |
| Q1 2020 | $29,869,000 | -9.8% | 215,800 | 0.0% | 4.22% | +22.9% |
| Q4 2019 | $33,121,000 | +6.3% | 215,800 | 0.0% | 3.44% | +2.1% |
| Q3 2019 | $31,168,000 | +1.1% | 215,800 | 0.0% | 3.36% | +1.2% |
| Q2 2019 | $30,842,000 | +8.3% | 215,800 | 0.0% | 3.32% | +11.3% |
| Q1 2019 | $28,490,000 | +28.0% | 215,800 | 0.0% | 2.98% | +19.2% |
| Q4 2018 | $22,253,000 | -5.1% | 215,800 | 0.0% | 2.50% | +5.0% |
| Q3 2018 | $23,449,000 | +10.1% | 215,800 | 0.0% | 2.38% | +1.7% |
| Q2 2018 | $21,295,000 | +0.8% | 215,800 | 0.0% | 2.34% | -5.7% |
| Q1 2018 | $21,129,000 | +5.5% | 215,800 | 0.0% | 2.49% | +5.2% |
| Q4 2017 | $20,031,000 | +8.2% | 215,800 | 0.0% | 2.36% | -1.2% |
| Q3 2017 | $18,511,000 | +1.6% | 215,800 | 0.0% | 2.39% | -2.6% |
| Q2 2017 | $18,211,000 | +1.2% | 215,800 | +2.6% | 2.46% | -4.1% |
| Q1 2017 | $17,996,000 | +9.9% | 210,400 | 0.0% | 2.56% | +10.1% |
| Q4 2016 | $16,378,000 | -0.7% | 210,400 | 0.0% | 2.33% | +18.7% |
| Q3 2016 | $16,493,000 | -22.4% | 210,400 | 0.0% | 1.96% | -20.0% |
| Q2 2016 | $21,250,000 | +57.9% | 210,400 | +48.3% | 2.45% | +58.3% |
| Q1 2016 | $13,461,000 | +118.6% | 141,900 | +114.0% | 1.55% | +84.1% |
| Q4 2015 | $6,158,000 | – | 66,300 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |